EVOLVE Trademark

Trademark Overview

On Wednesday, December 6, 2023, a trademark application was filed for EVOLVE with the United States Patent and Trademark Office. The USPTO has given the EVOLVE trademark a serial number of 98301538. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 28, 2024. This trademark is owned by Tavros Therapeutics, Inc.. The EVOLVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research and development, namely, research and development utilizing a precision oncology platform to develop cancer treatments; medical research in the field of oncology; pharmaceutical product research and development in the field of oncology; scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials
evolve

General Information

Serial Number98301538
Word MarkEVOLVE
Filing DateWednesday, December 6, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific and medical research and development, namely, research and development utilizing a precision oncology platform to develop cancer treatments; medical research in the field of oncology; pharmaceutical product research and development in the field of oncology; scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTavros Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressDurham, NC 27709

Trademark Events

Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Sunday, March 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 5, 2024ASSIGNED TO EXAMINER
Wednesday, July 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 10, 2024NON-FINAL ACTION E-MAILED
Monday, October 28, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, October 28, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords

evolve research oncology field development medical cancer scientific product purposes trials